Quarterly statement as at 30 September 2020

5 November 2020

Christoph Jurecka

Image: Klaus Ohlenschläger / dpa Picture Alliance

Quarterly statement

as at 30 September 2020

1

2

3

4

5

Munich Re ERGO

Reinsurance Outlook

Backup

Quarterly statement as at 30 September 2020

5 November 2020

2

Munich Re

1

Image: Vertigo3d / Getty ImagesiStockphoto

Munich Re - Financial highlights Q3 2020

Munich Re posts a decent Q3 result considering high major losses

Munich Re

Net result

€199m (€999m) Reinsurance result of €63m

impacted by COVID-19 related claims and other major losses - strong ERGO result of €136m

Return on investment1

2.7% (2.8%)

Reinsurance: 3.7% - benefited from disposal gains

Q3 2020 (9M 2020)

Technical result

Investment result

Net result

€m

€m

€m

2,431

5,826

5,308

2,490

606

2,150 1,691

865

999

538

87

199

Q3

Q3

9M

9M

Q3

Q3

9M

9M

Q3

Q3

9M

9M

2019

2020

2019

2020

2019

2020

2019

2020

2019

2020

2019

2020

ERGO: 2.1% - impacted by equity impairments and derivative losses

Shareholders' equity

29.6bn (-3.1% vs. 31.12.)

Return on equity1: 3.6% (5.9%)

Solvency II ratio: 216%

Reinsurance

Life and Health: Technical result incl. fee income: €56m (€160m) - Negative COVID-19 impact of ~€100m in Q3

- net result of €86m (€153m)

Property-casualty: 112.2% (106.1%) - Major-loss ratio:

26.7% (21.0%); Reserve releases2: -4.0%(-4.0%) - net result of -€23m (€446m)

ERGO

L&H Germany: RoI: 2.2% (2.6%) - net result of €31m (€99m)

Property-casualty Germany: C/R: 90.9% (92.2%) - net result of €48m (€120m)

International: C/R: 92.5% (92.6%) - net result of €57m (€162m)

1 Annualised. 2 For prior-year basic losses.

Quarterly statement as at 30 September 2020

5 November 2020

4

Munich Re - COVID-19

L&H reinsurance - Increase in COVID-19-related claims consistent with pandemic development in different regions

COVID-19 related losses in L&H reinsurance

  • Losses dominated by far by the US
  • Q3: ~€100m / 9M: ~€200m
  • 9M includes COVID-19 related claims expected to be incurred by 30 September - no specific provisions for COVID-19-related deaths after 30 September established
  • Limited loss activity on disability lines so far

Outlook/

Projection 2020

  • Claims development depends on further mortality experience, esp. in North America
  • As expected, portfolio mortality rates are well below that of the general population
  • Each 5% of extra mortality claims in our book leads to excess annual claims cost of ~€200m1
  • Still far away from 200-year event scenario2 of ~€1.4bn
  • Risk of disability claims depends on economic development
  • UK longevity is expected to offset UK mortality claims

1 Estimate based on a stress test with simplistic assumptions, e.g. no differentiation between markets, no specific age distributions of our exposure and lethality

Quarterly statement as at 30 September 2020

5 November 2020

5

of the pandemic.; only refers to mortality business. 2 Scenario based on the assumption of 10m incremental global deaths.

Munich Re - COVID-19

P-C reinsurance - Continuous worsening of the pandemic leaving its mark in Q3

COVID-19 related losses in P-C Reinsurance

  • Losses across various lines of business, contingency losses making up the largest share
  • Q3: ~€700m / 9M: ~€2.1bn
  • Material reserve increase in Q3 due to the continuous worsening of the pandemic and recent reintroduction of restrictions in many countries
  • 9M figures include COVID-19-related claims incurred through 30 September, reserved cautiously across affected lines of business
  • 9M: ~€300m in paid claims and client-reported case reserves in reinsurance, ~€1.8bn IBNR1

Outlook/

Projection 2020

  • Risk of further contingency claims continues, depending on development of the pandemic
  • Claims in other lines of business are also expected to increase
    • BI: focus on non-damage BI policies - contract wording is crucial (e.g. FCA ruling provides a differentiated view)
    • Less exposure to further deterioration expected in credit given government interventions and exposure management of our cedants
    • Less exposed in workers' comp. and D&O

1 Including €540m claims (direct business) for which we gave confirmation of coverage in 9M 2020.

Quarterly statement as at 30 September 2020

5 November 2020

6

Munich Re - Capitalisation

Capital position

Equity

€m

Equity 31.12.2019

30,576

Change in Q3

Consolidated result

999

199

Changes

Dividend

-1,373

0

Unrealised gains/losses

1,158

372

Exchange rates

-931

-651

Share buy-backs

-359

0

Other

-429

-45

Equity 30.9.2020

29,641

-125

Unrealised gains/losses

Exchange rates

Fixed-interest securities

Devaluation of various currencies,

9M: €1,885m

Q3: €306m

mainly USD

Non-fixed-interest securities

9M: -€743m

Q3: €62m

Capitalisation

€bn

0.3

0.3

0.3

0.3

0.3

3.8

5.0

3.9

3.7

3.7

13.2

12.6

15.1

12.0

11.9

26.5

30.6

29.1

29.8

29.6

2018

2019

31.3.2020

30.6.2020

30.9.2020

Debt leverage1 (%)

Senior and other debt

Subordinated debt

Equity

1 Strategic debt (senior, subordinated and other debt) divided by total capital (strategic debt + equity).

Quarterly statement as at 30 September 2020

5 November 2020

7

Munich Re - Investments

Investment portfolio

Investment portfolio1

% Portfolio management in Q3

Land and buildings 4.9 (4.7)

Miscellaneous2 8.1 (8.1)

Shares, equity funds and participating interests3 5.9 (7.1)

TOTAL

252bn

Fixed-interest securities 55.4 (53.9)

Loans

25.8 (26.1)

  • Investments in longer term US and Australian government bonds as well as short-term bank bonds and ABS at the expense of covered bonds
  • Slight expansion of equity exposure despite disposal of strategic equity investments
  • Ongoing increase of infrastructure and private equity investments
  • Drop in reinvestment yield to 1.3%

Portfolio duration1

Reinsurance

ERGO

Munich Re

DV011,4

€m

Assets Liabilities

Assets

Liabilities

Net

6.9 (6.5)

7.4 (6.3)

51 (46)

41 (34)

10

9.9 (9.4)

10.6 (10.1)

138 (126)

151 (139)

-13

8.9 (8.4)

9.7 (9.0)

189 (172)

192 (173)

-3

1 Fair values as at 30.9.2020 (31.12.2019). 2 Deposits retained on assumed reinsurance, deposits with banks, investment funds (excl. equities), derivatives

Quarterly statement as at 30 September 2020

5 November 2020

8

and investments in renewable energies and gold. 3 Net of hedges: 4.8% (6.4%). 4 Market value change due to a parallel downward shift in yield curve by

one basis point, considering the portfolio size of assets and liabilities (pre-tax). Negative net DV01 means rising interest rates are beneficial.

Munich Re (Group) - Investments

Investment result

€m

Q3 2020

Return1

9M 2020

Return1

9M 2019

Return1

Regular income

1,536

2.4%

4,801

2.6%

5,133

2.8%

Write-ups/write-downs

-265

-0.4%

-1,832

-1.0%

-285

-0.2%

Disposal gains/losses

644

1.0%

2,210

1.2%

1,671

0.9%

Derivatives2

-65

-0.1%

629

0.3%

-208

-0.1%

Other income/expenses

-159

-0.3%

-500

-0.3%

-485

-0.3%

Investment result

1,691

2.7%

5,308

2.8%

5,826

3.2%

Total return

3.8%

4.4%

12.1%

3-month

Write-ups/

Disposal

Write-ups/

Disposal

reinvestment yield

Q3 2020

write-downs gains/losses Derivatives

9M 2020

write-downs

gains/losses

Derivatives

Q3 2020

1.3%

Fixed income

-7

321

26

Fixed income

-22

1,358

605

Q2 2020

1.6%

Equities

-207

318

-103

Equities

-1,671

551

78

Commodities/Inflation

-2

0

22

Commodities/Inflation

39

0

38

Q1 2020

1.9%

Other

-50

5

-10

Other

-178

301

-91

1 Annualised return on quarterly weighted investments (market values) in %. 2 Result from derivatives without regular income and other income/expenses.

Quarterly statement as at 30 September 2020

5 November 2020

9

ERGO

2

Image: dem10 / iStockphoto Getty Images

ERGO

ERGO Life and Health Germany

Gross premiums written

€m

9M 2019

6,912

Foreign exchange

-1

Divestments/investments

0

Organic change

-193

9M 2020

6,718

Life (-€80m): Growth through new products

Major result drivers

€m

9M 2020

9M 2019

Q3 2020

Q3 2019

Technical result

331

234

96

306

81

225

Non-technical result

-56

-28

-28

-166

-128

-38

thereof investment result

2,454

2,985

-531

697

985

-288

Other

-175

-63

-112

-110

54

-164

Net result

99

143

-43

31

8

23

Technical result

Investment result

only partially compensating for ordinary

attrition of back book

Health (-€141m): Increase in comprehensive

and supplementary insurance, negative

COVID-19 effect in Travel

Digital Ventures (+€27m): Growth in health

insurance (esp. dental products)

  • Q3: Interdependency between investment and technical result - COVID-19 leading to high intra-year volatility with positive impact in Q3
  • 9M: Decrease in Travel due to COVID-19; improved result in Health
  • 9M: Higher impairments of equities during volatile capital market environment due to COVID-19, partly offset by disposal gains and hedging
  • Q3: Decrease driven by higher impairments and lower derivatives result; Return on investment of 2.2%

Other

  • FX result of -€91m in 9M (9M 2019: €54m),
    thereof -€65m in Q3 (Q3 2019: €94m)

Quarterly statement as at 30 September 2020

5 November 2020

11

ERGO

ERGO Property-casualty Germany

Gross premiums written

€m

9M 2019

2,804

Foreign exchange

5

Divestments/investments

0

Organic change

134

9M 2020

2,943

Major result drivers

€m

9M 2020

9M 2019

Q3 2020

Q3 2019

Technical result

237

231

6

92

81

11

Non-technical result

-34

-80

47

-14

-20

6

thereof investment result

122

105

17

29

34

-5

Other

-84

-46

-38

-30

-26

-4

Net result

120

105

15

48

36

13

  • Organic growth in almost all lines of business; mainly driven by fire/property (+€43m), liability (+€29m), motor (+€24m) and other insurance (+€35m)

Technical result

Combined ratio of 92.2% in 9M at guidance level, 90.9% in Q3 due to

  • Strong premium development
  • Nat-catlosses significantly below expectations
  • Minor COVID-19 effects from business closure and event cancellation; lower costs

Investment result

  • 9M: Disposal gains and hedging more than offset impairments on equities
  • Q3: Disposal gains partly offset impairments on equities and lower derivatives result
  • Q3: Return on investment of 1.5%

Quarterly statement as at 30 September 2020

5 November 2020

12

ERGO

ERGO Property-casualty Germany

Combined ratio

% Gross premiums written in 9M 2020 (9M 2019)

€m

  • Loss ratio Expense ratio

2018

96.0

62.5

33.4

2019

92.3

60.3

32.0

9M 2020

92.2

61.6

30.6

Q3 2020

90.9

61.9

29.0

97.9

98.1

92.1

93.2

93.4

92.5

90.9

86.2

Other

Motor

259 (224)

617 (593)

Marine 182 (165)

TOTAL

Fire/property

2,943m

585 (542)

(€2,804m)

Legal protection 316 (318)

Q4

Q1

Q2

Q3

Q4

Q1

Q2

Q3

Personal accident

Liability

449 (458)

534 (505)

2018

2019

2019

2019

2019

2020

2020

2020

Quarterly statement as at 30 September 2020

5 November 2020

13

ERGO

ERGO International

Gross premiums written

€m

9M 2019

3,657

Foreign exchange

-32

Divestments/investments

-103

Organic change

63

9M 2020

3,584

Life (-€37m): Lower level due to run-down in

Major result drivers

€m

9M 2020

9M 2019

Q3 2020

Q3 2019

Technical result

189

191

-2

78

96

-18

Non-technical result

20

1

19

1

44

-42

thereof investment result

260

298

-38

81

138

-57

Other

-47

-100

53

-22

-64

42

Net result

162

92

70

57

76

-19

Technical result

Investment result

Belgium and reduced new business in Austria

related to COVID-19

Health (+€66m): Positive business

development in Spain and Belgium

P-C (-€102m): Decrease mainly driven by

portfolio streamlining in 2019, lower growth in

Poland due to COVID-19

Highlights in Q3:

  • Life: Decrease driven by Belgium
  • Health: Good quarter due to seasonal effects, tariff increases and favourable claims development
  • P-C: Ongoing good operational performance (esp. Poland, Baltics), reduced attritional claims and lower large losses
  • 9M/Q3: Previous year impacted by disposal gains due to portfolio streamlining
  • Q3: Return on investment of 1.6%

Other

  • FX result of €0m in 9M (9M 2019: -€57m),
    thereof €1m in Q3 (Q3 2019: -€38m)

Quarterly statement as at 30 September 2020

5 November 2020

14

ERGO

ERGO International

Combined ratio

% Gross premiums written in 9M 2020 (9M 2019)

€m

94.5

95.4

95.0

91.8

94.8

95.2

90.1

Q4

Q1

Q2

Q3

Q4

Q1

Q2

2018

2019

2019

2019

2019

2020

2020

9M 2020

91.7 89.6 89.7 89.4 85.5 101.4

Poland Spain Austria Baltics Greece Legal protection

Property-casualty1,985 (2,087)

92.5

TOTAL

3,584m

(€3,657m)

Q3

2020

P-C

9M

9M

Life

92.6

thereof:

2020

2019

thereof:

Poland

1,056

1,080

Austria

Belgium

Legal protection

497

476

Greece

180

173

Health

Baltics

145

144

thereof:

Spain

Total

Austria

79

74

Belgium

Life 470 (507)

Health 1,129 (1,062)

9M 9M

2020 2019

  1. 266
  1. 114

9M 9M

2020 2019

  1. 615
  1. 448

Quarterly statement as at 30 September 2020

5 November 2020

15

Reinsurance

3

Image: John Lund Getty Images

Reinsurance

Reinsurance - Life and Health

Gross premiums written

€m

9M 2019

8,625

Foreign exchange

-33

Divestments/investments

0

Organic change

946

9M 2020

9,538

Major result drivers

€m

9M 2020

9M 2019

Q3 2020

Q3 2019

Technical result

31

322

-291

10

194

-184

Non-technical result

207

369

-162

110

103

7

thereof investment result

639

866

-227

239

279

-40

Other

-85

-75

-10

-34

-15

-19

Net result

153

617

-464

86

282

-196

  • Organic growth mainly in Asia and Europe, but also some growth across North America
  • Asia: Several new transactions and increases of shares/volumes under existing treaties
  • Europe: Positive impact from longevity transactions concluded in Q2

Technical result incl. fee income of €56m (€160m)

  • COVID-19-relatedclaims of ~€100m in Q2 and again inQ3, dominated by US mortality
  • In North America: non-COVID-19-related claims higher than expected and some impact from lower interest rates on claims reserves …
  • … largely offset by strong results in
    Europe and Asia as well as better-than- expected performance in Australia
  • Ongoing pleasing fee income

Investment result

  • 9M/Q3: Disposal gains on fixed income investments from ordinary portfolio turnover clearly exceed write-downs on equities from H1
  • Q3: Positive one-off effect from disposal of strategic equity investments
  • Q3: Return on investment: 3.2%

Other

  • FX result of -€5m in 9M (9M 2019: €83m),
    thereof -€19m in Q3 (Q3 2019: €41m)

Quarterly statement as at 30 September 2020

5 November 2020

17

Reinsurance

Reinsurance - Property-casualty

Gross premiums written

€m

9M 2019

16,920

Foreign exchange

-17

Divestments/investments

0

Organic change

1,576

9M 2020

18,479

  • Organic growth across almost all lines driven by business expansion and rate increases in traditional reinsurance …
  • … as well as in our Risk Solutions portfolio

Major result drivers

€m

9M 2020

9M 2019

Q3 2020

Q3 2019

Technical result

-182

1,453

-1,635

-399

87

-486

Non-technical result

762

341

421

334

306

28

thereof investment result

1,834

1,572

261

646

715

-69

Other

-115

-259

144

42

71

-29

Net result

466

1,535

-1,069

-23

464

-486

Technical result

Investment result

  • COVID-19-relatedclaims of ~€2.1bn in 9M: Gains on fixed-income/ real estate disposals

9M (thereof ~€0.7bn in Q3), contingency

and derivatives clearly exceed write-downs on

business accounts for the largest share

equities

Expense ratio improved due to cost

Q3: Disposal gains on fixed income and strategic

reductions and premium growth

equity investments

Underlying performance remains very

Q3: Return on investment: 3.9%

strong - normalised combined ratio at

Other

~97% in Q3 and 9M

FX result of €170m in 9M (9M 2019: €251m),

thereof -€20m in Q3 (Q3 2019: €137m)

Quarterly statement as at 30 September 2020

5 November 2020

18

Reinsurance

Reinsurance - Property-casualty

Combined ratio

%

Basic losses

Major losses

Expense ratio

111.6112.2

105.1

103.9

106.0

97.3

99.9

86.9

Q4

Q1

Q2

Q3

Q4

Q1

Q2

Q3

2018

2019

2019

2019

2019

2020

2020

2020

2018

99.4

53.6

11.6

34.2

100.2

2019

51.4

15.2

33.6

106.1

9M 2020

54.8

21.0

30.3

112.2

Q3 2020

55.6

26.7

29.9

Major

Reserve

Normalised

losses

Nat cat

Man-made

releases1

combined ratio2

9M 2020

21.0

5.1

15.9

-4.0

97.0

Q3 2020

26.7

8.3

18.4

-4.0

97.0

Ø Annual

~12.0

~8.0

~4.0

~-4.0

expectation

1 Basic losses prior years, already adjusted for directly corresponding sliding-scale and profit-commission effects.

Quarterly statement as at 30 September 2020

5 November 2020

19

2 Based on reserve releases of 4%-pts. Normalised combined ratio reflects a one-off shift between commissions and non-technical result of €29m in Q3 2020

(corresponding to -0.5%-pts. in Q3 and -0.2%-pts. in 9M).

Outlook

4

Image: Klaus Ohlenschläger / dpa Picture Alliance

Outlook 2020

Group

Gross premiums written

~€54bn

ERGO

Gross premiums written1

~17.5bn

Reinsurance

Gross premiums written

~€36bn

Net result

withdrawn

Net result1

~€530m

Net result

withdrawn

Return on investment1

~3%

Combined ratio

P-C Germany1

International1

~92%

~94%

Combined ratio

Technical result, incl. fee income

Property-casualty

Life and Health

withdrawn

withdrawn

1 Substantial risk of falling short of this guidance, subject to the further development of the COVID-19 pandemic.

Quarterly statement as at 30 September 2020

5 November 2020

21

Backup

5

Image: imaginima / Getty Images

Backup: Group finance and risk

Segment income statement Q3 2020

€m

Reinsurance

Reinsurance

ERGO

ERGO

ERGO

Total

L/H1

P-C

L/H Germany

P-C Germany

International

Q3 2020

Gross premiums written

3,127

6,798

2,254

808

1,162

14,150

Net earned premiums

2,844

5,680

2,254

917

1,133

12,827

Income from technical interest

169

286

904

17

94

1,470

Net expenses for claims and benefits

-2,504

-4,666

-2,482

-576

-844

-11,072

Net operating expenses

-499

-1,698

-369

-266

-305

-3,137

Technical result

10

-399

306

92

78

87

Investment result

239

646

697

29

81

1,691

Insurance-related investment result

24

-10

116

0

46

175

Other operating result

17

-16

-75

-26

-31

-131

Deduction of income from technical interest

-169

-286

-904

-17

-94

-1,470

Non-technical result

Operating result

110

334

-166

-14

1

265

120

-65

140

78

79

353

Other non-operating result

1

-2

-29

-7

5

-31

Currency result

-19

-20

-65

4

1

-100

Net finance costs

-10

-31

-6

-2

-7

-54

Taxes on income

-6

96

-10

-25

-22

32

Net result

86

-23

31

48

57

199

Tax rate

7.0%

80.8%

24.8%

33.9%

27.7%

-19.4%

1 Technical result incl. fee income: €56m.

Quarterly statement as at 30 September 2020

5 November 2020

23

Backup: Group finance and risk

Segment income statement 9M 2020

€m

Reinsurance

Reinsurance

ERGO

ERGO

ERGO

Total

L/H1

P-C

L/H Germany

P-C Germany

International

9M 2020

Gross premiums written

9,538

18,479

6,718

2,943

3,584

41,261

Net earned premiums

8,575

16,668

6,743

2,635

3,367

37,988

Income from technical interest

501

837

2,010

51

55

3,455

Net expenses for claims and benefits

-7,491

-12,634

-7,379

-1,642

-2,306

-31,453

Net operating expenses

-1,554

-5,053

-1,043

-806

-927

-9,383

Technical result

31

-182

331

237

189

606

Investment result

639

1,834

2,454

122

260

5,308

Insurance-related investment result

34

-43

-276

0

-89

-374

Other operating result

35

-192

-223

-105

-96

-580

Deduction of income from technical interest

-501

-837

-2,010

-51

-55

-3,455

Non-technical result

Operating result

207

762

-56

-34

20

899

238

580

275

203

209

1,505

Other non-operating result

1

-10

-32

-12

5

-48

Currency result

-5

170

-91

-7

0

67

Net finance costs

-29

-93

-16

-5

-20

-164

Taxes on income

-51

-181

-36

-60

-32

-360

Net result

153

466

99

120

162

999

Tax rate

25.0%

28.0%

26.4%

33.5%

16.7%

26.5%

1 Technical result incl. fee income: €160m.

Quarterly statement as at 30 September 2020

5 November 2020

24

Backup: Group finance and risk

Actual vs. analysts' consensus

Operating result - Actual vs. analysts' consensus1

€m

KPIs - Actual vs. analysts' consensus1

€m

Q3 2020

Consensus Difference

Q3 2020

Consensus

Impact2

Reinsurance Property-casualty

-65

-57

-8

Combined ratio

112.2%

109.2%

-172

Reinsurance Life and Health

120

98

22

Tech. result incl. fee income

€56m

ERGO Life and Health Germany

140

132

8

ERGO Property-casualty Germany

78

87

-9

Combined ratio

90.9%

91.8%

8

ERGO International

79

82

-3

Combined ratio

92.5%

94.4%

16

Operating result

353

342

11

RoI by segment - Actual vs. analysts' consensus

FX

-100

Reinsurance P-C

Other

-86

Reinsurance L&H

ERGO L&H Germany

Taxes

32

ERGO P-C Germany

Net result

199

195

4

ERGO International

3.9%

Presumably

3.2%

above consensus

2.2%

Presumably

1.5%

below consensus

1.6%

1 Simple average of estimates the Munich Re Investor Relations team has gathered from analysts covering Munich Re, not taking into account any external

Quarterly statement as at 30 September 2020

5 November 2020

25

data providers. 2 Difference between actual and consensus times net earned premiums.

Backup: Group finance and risk

Premium development

Gross premiums written

€m

38,917

9M 2019

Foreign

-78

exchange

Divestments/

-103

investments

Organic

2,526

change

9M 2020

41,261

Segmental breakdown

Reinsurance

Property-casualty

18,479 (45%) ( 9.2%)

TOTAL

41.3bn

Reinsurance

Life and Health

9,538 (23%) ( 10.6%)

€m

ERGO Life and Health Germany

6,718 (16%) ( -2.8%)

ERGO Property-casualty Germany

2,943 (7%) ( 4.9%)

ERGO

International

3,584 (9%) ( -2.0%)

Quarterly statement as at 30 September 2020

5 November 2020

26

Backup: Reinsurance

Development of combined ratio

Combined ratio vs. basic losses (%)

Combined ratio

Basic loss ratio

103.9

88.6

102.0

100.7

105.1

97.3

86.9

103.9

111.6

106.0

99.9

112.2

55.6

53.2

55.7

55.3

50.4

54.8

50.1

54.7

46.4

54.7

54.1

55.6

Q4 2017

Q1 2018

Q2 2018

Q3 2018

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Q2 2020

Q3 2020

Nat cat vs. man-made(%)

Nat cat ratio

12.0

Man-made ratio

14.1

21.1

17.4

11.7

11.0

10.5

5.7

10.8

2.6

3.1

0.0

-1.1

2.3

2.0

3.8

4.0

0.9

7.6

6.3

3.7

3.1

18.4

8.3

Q4 2017

Q1 2018

Q2 2018

Q3 2018

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Q2 2020

Q3 2020

Quarterly statement as at 30 September 2020

5 November 2020

27

Backup: Group finance and risk - Investments

Return on investment by asset class and segment

9M 2020

%1

Regular

Write-ups/

Disposal

Extraord.

Other

ᴓ Market

income

-downs

result

derivatives result

inc./exp.

RoI

value (€m)

Afs fixed-income

2.0

0.0

1.0

-

-

3.0

134,700

Afs non-fixed-income

4.8

-13.4

4.4

-

-

-4.2

16,599

Derivatives

4.0

-

-

27.5

-1.1

30.4

3,048

Loans

2.7

0.0

0.7

-

-

3.4

64,917

Real estate

4.6

-1.2

3.2

-

-

6.6

12,173

Other2

2.6

-0.3

0.1

-

-3.6

-1.1

17,637

Total

2.6

-1.0

1.2

0.3

-0.3

2.8

249,073

Reinsurance

2.6

-0.4

1.1

0.5

-0.3

3.5

95,282

ERGO

2.6

-1.3

1.2

0.2

-0.2

2.5

153,791

3.4%

Return on investment

Average 3.0%

3.2%

3.4%

3.2%

3.1%

3.1%

3.1%

3.0%

2.7%

2.9%

2.7%

2.3%

Q4 2017

Q1 2018

Q2 2018

Q3 2018

Q4 2018

Q1 2019

Q2 2019

Q3 2019

Q4 2019

Q1 2020

Q2 2020

Q3 2020

1 Annualised. 2 Including management expenses.

Quarterly statement as at 30 September 2020

5 November 2020

28

Backup: Investments

Investment result - Reinsurance

Reinsurance Life and Health (€m)

Q3 2020

Return1

9M 2020

Return1

9M 2019

Return1

Regular income

186

2.5%

572

2.6%

600

2.9%

Write-ups/write-downs

-4

0.0%

-18

-0.1%

0

0.0%

Disposal gains/losses

80

1.1%

130

0.6%

274

1.3%

Derivatives2

-3

0.0%

17

0.1%

4

0.0%

Other income/expenses

-21

-0.3%

-63

-0.3%

-13

-0.1%

Investment result

239

3.2%

639

2.9%

866

4.1%

Average market value

29,675

29,499

27,961

Reinsurance Property-casualty(€m)

Q3 2020

Return1

9M 2020

Return1

9M 2019

Return1

Regular income

414

2.5%

1,268

2.6%

1,420

3.0%

Write-ups/write-downs

-57

-0.3%

-281

-0.6%

-114

-0.2%

Disposal gains/losses

322

2.0%

682

1.4%

444

0.9%

Derivatives2

25

0.2%

345

0.7%

10

0.0%

Other income/expenses

-58

-0.4%

-180

-0.4%

-187

-0.4%

Investment result

646

3.9%

1,834

3.7%

1,572

3.3%

Average market value

65,694

65,783

63,310

1 Return on quarterly weighted investments (market values) in % p.a. 2 Result from derivatives without regular income and other income/expenses.

Quarterly statement as at 30 September 2020

5 November 2020

29

Backup: Investments

Investment result - ERGO

Life and Health Germany (€m)

Q3 2020

Return1

9M 2020

Return1

9M 2019

Return1

Regular income

819

2.6%

2,587

2.7%

2,722

2.9%

Write-ups/write-downs

-182

-0.6%

-1,426

-1.5%

-180

-0.2%

Disposal gains/losses

217

0.7%

1,280

1.3%

827

0.9%

Derivatives2

-78

-0.2%

244

0.3%

-137

-0.1%

Other income/expenses

-78

-0.2%

-231

-0.2%

-248

-0.3%

Investment result

697

2.2%

2,454

2.6%

2,985

3.2%

Average market value

128,327

127,160

125,888

Property-casualty Germany (€m)

Q3 2020

Return1

9M 2020

Return1

9M 2019

Return1

Regular income

35

1.8%

115

2.0%

119

2.1%

Write-ups/write-downs

-19

-1.0%

-82

-1.5%

-23

-0.4%

Disposal gains/losses

17

0.9%

91

1.6%

73

1.3%

Derivatives2

-7

-0.4%

6

0.1%

-44

-0.8%

Other income/expenses

4

0.2%

-8

-0.1%

-19

-0.3%

Investment result

29

1.5%

122

2.2%

105

1.9%

Average market value

7,566

7,520

7,495

1 Return on quarterly weighted investments (market values) in % p.a. 2 Result from derivatives without regular income and other income/expenses.

Quarterly statement as at 30 September 2020

5 November 2020

30

Backup: Investments

Investment result - ERGO

International (€m)

Q3 2020

Return1

9M 2020

Return1

9M 2019

Return1

Regular income

83

1.7%

259

1.8%

273

2.0%

Write-ups/write-downs

-4

-0.1%

-25

-0.2%

32

0.2%

Disposal gains/losses

9

0.2%

28

0.2%

53

0.4%

Derivatives2

-2

0.0%

17

0.1%

-41

-0.3%

Other income/expenses

-6

-0.1%

-18

-0.1%

-19

-0.1%

Investment result

81

1.6%

260

1.8%

298

2.2%

Average market value

19,630

19,110

18,097

1 Return on quarterly weighted investments (market values) in % p.a. 2 Result from derivatives without regular income and other income/expenses.

Quarterly statement as at 30 September 2020

5 November 2020

31

Backup: Investments

Sensitivities to interest rates, spreads and equities1

Sensitivity to risk-free interest in €bn (change in basis points)

-50bps-25bps +50bps

+100bps

Change in market value, gross

+10.2

+5.0

-9.2

-17.4

Change in on-balance-sheet reserves, net

+2.8

+1.4

-2.6

-4.9

Change in off-balance-sheet reserves, net

+0.4

+0.2

-0.4

-0.8

P&L (Investment result), gross

+0.4

+0.2

-0.4

-0.8

P&L, net

+0.2

+0.1

-0.2

-0.4

Sensitivity to spreads2 in €bn (change in basis points)

+50bps

+100bps

Change in market value, gross

-6.2

-11.7

Change in on-balance-sheet reserves, net

-1.5

-2.8

Change in off-balance-sheet reserves, net

-0.3

-0.5

P&L (Investment result), gross

-0.3

-0.6

P&L, net

-0.1

-0.2

Sensitivity to share prices3 in €bn (change in %)

-30%

-10%

+10%

+30%

Change in market value, gross

-1.7

-0.7

+0.6

+1.4

Change in on-balance-sheet reserves, net

-0.5

-0.2

+0.4

+1.1

P&L (Investment result), gross

-0.8

-0.4

-0.3

-1.4

P&L, net

-0.4

-0.2

-0.0

-0.2

1 Rough calculation with limited reliability assuming unchanged portfolio as at 30.9.2020. After rough estimation of policyholder participation and deferred tax;

linearity of relations cannot be assumed. Approximation - not fully comparable with IFRS figures. 2 Sensitivities to changes of spreads are calculated for

Quarterly statement as at 30 September 2020

5 November 2020

32

every category of fixed income portfolio, except government securities with AAA ratings. 3 Sensitivities to change in share prices are calculated for listed

shares only; assumptions: equity impairments as soon as market value drops below acquisition cost and best-estimate calculation of hedging impact.

Backup: Investments

On- and off-balance-sheet reserves

€m

31.12.

31.12.

30.6.

2018

2019

2020

Market value of investments

231,876

247,310

249,858

Total reserves

22,002

33,120

35,321

On-balance-sheet reserves

Fixed-interest securities

4,953

10,738

13,058

Non-fixed-interest securities

1,817

3,632

2,355

Other on-balance-sheet reserves1

207

203

130

Subtotal

6,977

14,574

15,544

Off-balance-sheet reserves

30.9.

2020

in Q3

251,928

2,070

36,040

719

13,867

809

2,366

11

130

0

16,364

820

Real estate2

4,769

5,600

5,631

5,668

37

Loans3

9,453

12,147

13,292

13,079

-213

Associates

803

799

855

930

75

Subtotal

15,024

18,546

19,778

19,676

-101

Reserve ratio

9.5%

13.4%

14.1%

14.3%

0.2 pp

1

Unrealised gains/losses from unconsolidated affiliated companies, valuation at equity and cash-flow hedging.

Quarterly statement as at 30 September 2020

5 November 2020 33

2

Excluding reserves from owner-occupied property. 3 Excluding insurance-related loans.

Backup: Investments

On- and off-balance-sheet reserves

€m

On-balance-sheet reserves

Off-balance-sheet reserves1

Total reserves (gross)

16,364

19,676

Provision for deferred premium refunds

-6,501

-11,690

Deferred tax

-2,295

-2,439

Minority interests

-9

-

Consolidation and currency effects

-101

-

Shareholders' stake

7,458

5,547

1 Excluding reserves for owner-occupied property and insurance-related loans.

Quarterly statement as at 30 September 2020

5 November 2020

34

Backup: Shareholder information

Changes to shares in circulation

Acquisition of

Retirement of

30.9.

Shares

31.12. own shares in

own shares in

2020

(millions)

2019

9M 2020

9M 2020

Shares in

141.5

-1.4

-

140.1

circulation

Treasury

2.9

1.4

-4.2

-

shares

Total

144.3

-

-4.2

140.1

Weighted average number of shares in circulation (millions)

148.7

143.6

140.3

140.1

2018

2019

9M 2020

Q3 2020

Quarterly statement as at 30 September 2020

5 November 2020

35

Backup: Shareholder information

Financial calendar

2020

8 December

2021

25 FEBRUARY

17 MARCH

28 APRIL

6 MAY

10 AUGUST

9 NOVEMBER

Investor Day

Balance sheet media conference for 2020 financial statements Analysts' and Investors' call

Annual report (Group), Annual report (Company) Annual General Meeting 2021

Quarterly statement as at 31 March 2021

Half-year financial report as at 30 June 2021

Quarterly statement as at 30 September 2021

Quarterly statement as at 30 September 2020

5 November 2020

36

Backup: Shareholder information

For information, please contact

Investor Relations Team

Christian Becker-Hussong

Thorsten Dzuba

Christine Franziszi

Head of Investor & Rating Agency Relations

Tel.: +49 (89) 3891-8030

Tel.: +49 (89) 3891-3875

Tel.: +49 (89) 3891-3910

Email: tdzuba@munichre.com

Email: cfranziszi@munichre.com

Email: cbecker-hussong@munichre.com

Ralf Kleinschroth

Andreas Silberhorn (Rating agencies)

Ingrid Grunwald (ESG)

Tel.: +49 (89) 3891-4559

Tel.: +49 (89) 3891-3366

Tel.: +49 (89) 3891-3517

Email: rkleinschroth@munichre.com

Email: asilberhorn@munichre.com

Email: igrunwald@munichre.com

Maximiliane Gerstner (ERGO)

Tel.: +49 (211) 477-7483

Email: maximiliane.gerstner@ergo.de

Münchener Rückversicherungs-Gesellschaft | Investor & Rating Agency Relations | Königinstraße 107 | 80802 München, Germany

Fax: +49 (89) 3891-9888 | Email: IR@munichre.com | Internet: www.munichre.com

Quarterly statement as at 30 September 2020

5 November 2020

37

Disclaimer

This presentation contains forward-looking statements that are based on current assumptions and

forecasts of the management of Munich Re. Known and unknown risks, uncertainties and other factors could lead to material differences between the forward-looking statements given here and the actual development, in particular the results, financial situation and performance of our Company. Obvious fluctuations in

the incidence of major losses as well as pronounced volatility of the capital markets and exchange rates - as well as the special features of IFRS accounting make an accurate forecast of results impossible. Moreover, there is considerable uncertainty regarding the further development of the coronavirus pandemic. The Company assumes no liability to update these forward-lookingstatements or to make them conform

to future events or developments. Figures from Q1 2019 onwards are restated reflecting the new cost- allocation method.

Quarterly statement as at 30 September 2020

5 November 2020

38

Attachments

  • Original document
  • Permalink

Disclaimer

Munich Re Group - Münchener Rück AG published this content on 05 November 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 November 2020 08:41:08 UTC